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Abstract
Observational studies suggest an inverse association between total dairy product intake and diabetes risk. However, there is a lack of
information on the relationship of specific dairy products with impaired glucose metabolism (IGM) and type 2 diabetes mellitus (T2DM).
Individuals aged 40–75 years were recruited for the Maastricht Study. All the participants filled out a 253-food item FFQ, covering fifty specific
dairy items that captured differences between full-fat, semi-skimmed and skimmed products, as well as fermented and non-fermented
products. Glucose metabolism status was assessed by an oral glucose tolerance test, and participants were informed on their glucose
metabolism status after returning the FFQ. Data of 2391 individuals were available to estimate OR (95% CI) for IGM (n 470) and newly
diagnosed (ND) T2DM (n 125), with adjustment for age, sex, BMI, physical activity, smoking status, education, energy intake and intakes of
vegetables, fruits, meat and fish. For IGM, fully adjusted analyses revealed inverse associations, with OR comparing the highest with the lowest
tertile of intake of 0·73 (95% CI 0·55, 0·96) for skimmed products and 0·74 (95% CI 0·54, 0·99) for fermented products. These dairy products
were not associated with ND T2DM. In contrast, full-fat products were positively associated with ND T2DM (OR 2·01; 95% CI 1·16, 3·47),
whereas total dairy product intake was inversely associated with ND T2DM (OR 0·50; 95% CI 0·26, 0·93). In conclusion, individuals with a high
consumption of skimmed and fermented products had lower odds of having IGM, and individuals with a high consumption of total dairy
products had lower odds of having ND T2DM. High intake of full-fat products was not related to IGM but was positively related to ND T2DM.
Key words: Dairy foods: FFQ: Impaired glucose metabolism: Newly diagnosed type 2 diabetes mellitus: Observational studies
Type 2 diabetes mellitus (T2DM) is a metabolic disorder
characterised by sustained hyperglycaemia. Hyperglycaemia in
T2DM is due to insulin resistance, resulting from impaired
sensitivity of tissues for insulin, and relative insulin deficiency.
The prevalence worldwide of T2DMwill increase from its present
level of 225 million to as many as 552 million people by 2030(1).
Diabetes accelerates the development of other chronic diseases
such as CVD, cognitive problems and decreased quality of life.
Therefore, it is crucial to prevent diabetes and improve health
status by identifying modifiable lifestyle factors including diet(2).
Previous studies have demonstrated positive associations
of circulating total free fatty acids with pancreatic β-cell
dysfunction(3) and insulin resistance(4). Other studies have
suggested a negative association between dietary dairy-derived
fatty acids and diabetes(5–7). Up to now, five meta-analyses(8–12)
have summarised the results of prospective studies(12–15) and
randomised controlled trials(16,17) on dairy product consump-
tion and diabetes risk. Generally, these studies revealed
an inverse relationship between consumption of total dairy
products and T2DM.
Despite the presence of several meta-analyses on dairy
consumption and T2DM, there is still a striking lack of
knowledge regarding the role of specific dairy foods in the
aetiology of T2DM, and studies have revealed mixed results on
Abbreviations: IGM, impaired glucose metabolism; ND, newly diagnosed; NGM, normal glucose metabolism; T2DM, type 2 diabetes mellitus.
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the relationship between specific dairy products and diabetes.
For example, most studies have observed inverse associations
between yogurt consumption and T2DM risk(10–12,18). In addition,
cheese consumption was not associated with the incidence of the
metabolic syndrome and/or T2DM(13). However, cheese intake
showed a, although not statistically significant, inverse association
with diabetes incidence in the European Prospective Investigation
into Cancer and Nutrition (EPIC) – InterAct Study(19) and the
Malmö Diet and Cancer cohort(20). Furthermore, within Europe,
substantial differences across countries exist with regard to con-
sumption amounts of both total and specific dairy products(21).
For instance, total dairy product intake is relatively high in Spain
and the Netherlands, whereas yogurt consumption is relatively
high in Sweden and the Netherlands compared with other Eur-
opean countries(21). Moreover, none of the publications so far
have included impaired glucose metabolism (IGM), which is
associated with an increased T2DM risk as an outcome(22). In line
with the expected rise in incidence of T2DM(23), data from the
1999–2010 National Health and Nutrition Examination Survey
revealed a 21% increase in IGM prevalence from 1999 through
2010(24), whereas IGM prevalence will rise further from 344 mil-
lion in 2010 to an estimated 472 million in 2030(25). The aetiolo-
gical hypothesis that dairy product intake is inversely associated
with diabetes risk would be strengthened if associations between
dairy product intake and IGM, a potential pre-stage of diabetes,
have similar direction and magnitude compared with associations
between dairy product intake and diabetes. The Maastricht Study
is an extensive phenotyping study that focuses on the aetiology of
T2DM, its classic complications and its emerging co-
morbidities(26). Within the framework of this cohort, we applied
an extensive FFQ capturing fifty specific dairy products. The
presence of data from an oral glucose tolerance test (OGTT),
performed in all participants, also including individuals with
normal glucose metabolism (NGM), allowed us to investigate
associations of the consumption of specific dairy products with
both IGM and newly diagnosed (ND) T2DM. In the present study,
we included only individuals with IGM and ND T2DM because all
individuals with pre-existing T2DM would have received advice
on how to change their lifestyle, including their diet(27).
Methods
Study design, study area and population
In this study, we used data from the Maastricht Study, an
observational prospective population-based cohort study. The
rationale and methodology have been described previously(26).
In brief, the study focuses on the aetiology, pathophysiology,
complications and co-morbidities of T2DM and is characterised
by an extensive phenotyping approach. Eligible for participa-
tion were all individuals aged between 40 and 75 years and
living in the southern part of the Netherlands. Participants
were recruited through mass media campaigns and from the
municipal registries and the regional Diabetes Patient Registry
via mailings. Recruitment was stratified according to known
T2DM status for reasons of efficiency. The present report
includes cross-sectional data from the first 3451 participants,
who completed the baseline survey between November 2010
and September 2013. The examinations of each participant
were performed within a time window of 3 months. All parti-
cipants filled out a FFQ of the Maastricht Study after their first
visit to the study centre and returned their completed FFQ by
the third visit. Upon return of the FFQ, participants were
informed about their glucose metabolisms status (e.g. normal
glucose tolerance, IGM or diabetes). Participants who had
previously been diagnosed with T2DM (n 883) were excluded
from the present analyses as they already would have received
dietary advice(27), which likely would have changed their
dietary habits. From the remaining 2568 participants, 117
individuals had not returned their FFQ, and sixty individuals
had implausible energy intakes (<3347 or >17 573 kJ/d (<800
or >4200 kcal/d) for men and <2092 or >14 644 kJ/d (<500 or
>3500 kcal/d) for women)(28), and were therefore excluded as
well. Finally, a total of 2391 participants (1796 with normal
glucose tolerance, 470 with IGM and 125 with ND T2DM) were
included in the present analyses.
The present study was approved by the institutional medical
ethical committee (NL31329.068.10) and the Minister of Health,
Welfare and Sports of the Netherlands, on the basis of the
Health Council’s opinion (Permit 131088-105234-PG). All the
participants gave their written informed consent.
Data collection
Oral glucose tolerance test. To determine glucose metabolism
status, all the participants (except those who use insulin) under-
went a standardised seven-point OGTT after an overnight fast.
Blood samples collected at baseline and 120min after ingestion
of a 75-g glucose drink were used to define diabetes status
according to the World Health Organization 2006 criteria(29) into
NGM, impaired fasting glucose (IFG), impaired glucose tolerance
(IGT) and T2DM. In the present study, individuals with IFG or
IGT were combined into one category – that is, IGM.
Dietary intake. Dietary intake was assessed by a tailor-made FFQ
developed using the Dutch national FFQ tool(30). The FFQ used in
the Maastricht Study is one of the most extensive FFQ used so far in
any study. It contains 101 questions on consumption over the last
year, comprising twenty-three product groups and 253 items. The
FFQ collected information on the intake of major food groups such
as vegetables, fruits, meat, fish, dairy products and alcohol. Dairy
product intake was appraised by fifty items covering milk (four
items), chocolate milk (one item), coffee creamer (four items),
ready-to-eat porridge (one item), cheese (nine items), yogurt
(seven items), drink yogurt (three items), curd cheese (seven
items), custard (six items), butter (two items), cream (four items)
and ice cream (two items). Moreover, the FFQ captured differences
between full cream, semi-skimmed and skimmed products, as well
as fermented and non-fermented products (Table 1). Intake of
energy and specific nutrients (SFA, Ca and lactose) was calculated
using the Dutch NEVO food composition table, version 2011(31).
Other relevant health parameters. All measurements were
performed by trained research assistants during visits to the
Maastricht Study research centre using standardised protocols.
During study visits, office blood pressure (mmHg) was measured,
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and weight and height were measured to the nearest 0·1 cm and
0·5kg(26), respectively, to calculate BMI (kg/m2). Information on
age and sex was extracted from study files, and information on
education level (low, middle, high), physical activity, smoking
habits (never, former, current) and self-reported medical
history of CVD (yes, no) was derived from self-reported health
questionnaires. Laboratory assessments included total cholesterol,
LDL-cholesterol and HDL-cholesterol and TAG. Details about
these measurements have been presented elsewhere(26).
Statistical analysis
Statistical analyses were performed using SAS version 9.3 (SAS
Institute Inc.). Logistic regression models were fitted to estimate
OR and their 95% CI for the association between dairy product
consumption and presence of IGM and ND T2DM. Crude models
(model 1) were adjusted for age and sex. Fully adjusted multi-
variable models (model 2) were adjusted for sex, age, education
(low, middle, high), BMI (continuous), physical activity (h/week),
smoking (never, former, current) and intakes of energy, alcohol,
vegetables, fruits, meat and fish. Associations were analysed with
consumption of dairy product products expressed both as con-
tinuous measures (per serving for specific dairy products, and per
100 g increment for combined dairy categories) and as categorical
variables, with tertile cut-off points based on intake of the NGM
participants in our study population. All tests were two-tailed, and
P values< 0·05 were considered statistically significant.
Results
Characteristics of study population
Of the 2391 participants included in this study, 1796 individuals
had NGM, 470 had IGM and 125 were ND with T2DM.
The mean age was 59·9 (SD 8·2) years and 50·9% were men.
Altogether, 12·6% of the participants were current smokers and
17·0% reported a medical history of CVD. Compared with
individuals with NGM, individuals with IGM or ND T2DM were
more frequently male, were older and had higher BMI, lower
physical activity, higher blood pressure and a higher prevalence
of CVD. Moreover, individuals with IGM or ND T2DM tended
to have lower intakes of fruits and vegetables and higher
intakes of meat, whereas fish consumption was similar across
subgroups of glucose metabolism status (Table 2).
Intake (g/d) of dairy products
The mean intake of total dairy products was 159 (SD 137) g/d in
individuals with normal glucose tolerance compared with an
average intake of 119 (SD 93) g/d in individuals with ND T2DM
(Pfor difference< 0·01). Cheese was consumed by all participants
and yogurt by approximately 80%. Just over 50% of the total
study population consumed milk and approximately 40%
consumed butter. Butter milk, drink yogurt and curd cheese
were consumed by a smaller proportion of the participants
(<35%). The consumption of milk was essentially the same for
NGM, IGM and ND T2DM. The most pronounced differences
across groups of glucose metabolism status were observed for
the amount of consumption of yogurt, fermented, skimmed and
semi-skimmed products and for total dairy product intake, with
the highest intakes in individuals with NGM and the lowest
intakes in individuals with ND T2DM (data not shown, online
Supplementary Table S1).
Individuals in the highest tertile of yogurt intake (≥63 g/d)
had higher physical activity levels, were less often current
smokers and consumed more fruits and vegetables and less
meat compared with individuals in the lowest tertile of yogurt
intake (≤10·5 g/d). Similar patterns were observed for individuals
Table 1. Categorisation of fifty dairy food items into specific categories
Dairy products Composition
Total products All dairy products mentioned below, plus coffee milk, chocolate milk and porridge
Full-fat products Full-fat milk, Dutch cheese, foreign cheese, full-fat natural fruit yogurt and fruit curd cheese
Semi-skimmed products Low-fat milk, Dutch cheese, foreign cheese, low-fat natural fruit yogurt and fruit curd cheese
Skimmed products Skimmed milk, Dutch cheese, foreign cheese, skimmed natural fruit yogurt and fruit curd cheese
Fermented products Whole-fat, low-fat and skimmed yogurts (both natural and with fruit)
Whole-fat, low-fat and skimmed cheese (both Dutch and foreign, also including spreadable cheese)
Whole-fat, low-fat and skimmed curd cheese (both natural and with fruit), butter milk
Non-fermented, basic All types of milk and chocolate milk
Non-fermented, dessert Whole-fat and low-fat cream, cooking cream, ice cream
Whole-fat, low-fat and semi-skimmed custard
Milk Whole-fat, low-fat and skimmed milk
Cheese, total Dutch cheese: whole-fat, low-fat and skimmed cheese, also including spreadable cheese
Foreign cheese: whole-fat, skimmed and spreadable cheese
Cheese, Dutch Whole-fat, low-fat and skimmed cheese, also including spreadable cheese
Cheese, foreign Foreign cheese: whole-fat, skimmed and spreadable cheese
Yogurt, total Natural: whole-fat, low-fat and skimmed yogurt
Fruit: whole-fat, low fat and skimmed yogurt, and skimmed yogurt with artificial sweeteners
Yogurt, natural Natural: whole-fat, low-fat and skimmed yogurt
Yogurt, fruits Fruit: whole-fat, low-fat and skimmed yogurt, and skimmed yogurt with artificial sweeteners
Drink yogurt Natural, with sugar, with artificial sweeteners
Curd cheese, total Natural: whole-fat, low-fat and skimmed curd cheese
Fruit: whole-fat, low-fat and skimmed curd cheese, and skimmed curd cheese with artificial sweeteners
Curd cheese, natural Natural: whole-fat, low-fat and skimmed curd cheese
Curd cheese, fruits Fruit: whole-fat, low-fat and skimmed curd cheese, and skimmed curd cheese with artificial sweeteners
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in the highest intake tertile of fermented, skimmed and semi-
skimmed products and total dairy products (data not shown).
Associations between consumption of dairy products with
the presence of impaired glucose metabolism or newly
diagnosed type 2 diabetes mellitus
Age- and sex-adjusted analyses revealed significant inverse
associations of total dairy, skimmed and fermented dairy
products, as well as of cheese (both for total cheese and Dutch
cheese) and yogurt, with IGM. After further adjustment for BMI,
physical activity, smoking status, education and intakes of
energy, vegetables, fruits, meat and fish, the associations of total
dairy product intake and cheese with IGM were no longer
statistically significant. The other associations remained sig-
nificant, with OR, comparing the third with the first tertile, of
0·73 (95% CI 0·55, 0·96) for skimmed products, 0·74 (95% CI
0·54, 0·99) for fermented products and 0·67 (95% CI 0·50, 0·90)
for yogurt. In continuous analyses, the OR per 100 g increment
in fermented products and per serving of yogurt were only
statistically significant in the age- and sex-adjusted models,
whereas fully adjusted OR was 0·88 (95% CI 0·80, 0·97)
per serving (20 g increment) of Dutch cheese consumption
(Table 4). Semi-skimmed, full-fat and non-fermented products,
as well as milk and curd cheese, were not associated with IGM
in any of the models (Table 3).
Age- and sex-adjusted analyses of the association between
dairy products and ND T2DM revealed significant inverse
associations for total dairy products, semi-skimmed products,
fermented products and yogurt, whereas full-fat products were
positively associated with ND T2DM. Fully adjusted models
comparing the third with the first tertile revealed OR of 0·50
(95% CI 0·26, 0·93) for total dairy product intake, but an
increased OR of 2·01 (95% CI 1·16, 3·47) for full-fat dairy pro-
ducts. Even though fully adjusted OR comparing the third v. the
first tertile were not significant for total dairy product intake,
fermented products and yogurt, the fully adjusted continuous
models showed OR of 0·76 (95% CI 0·61, 0·95) per 100 g
increment in total dairy product intake, 0·69 (95% CI 0·50, 0·94)
per 100 g increment in fermented products and 0·47 (95% CI
0·24, 0·89) per serving (150ml) for yogurt (Table 4), respec-
tively. Non-fermented products, cheese and curd cheese were
not associated with ND T2DM (Table 4).
Mutual adjustment for the associations of full-fat products
with skimmed products and vice versa and of fermented pro-
ducts with non-fermented products did not alter the observed
associations with IGM and ND T2DM.
Discussion
This is the first epidemiological study on the association of
specific dairy products with both ND T2DM and IGM as
outcomes. Detailed information on dairy product intake was
collected using an extensive, 253-item, tailor-made FFQ that
included fifty dairy items, and associations were extensively
Table 2. Population characteristics
(Mean values and standard deviations)
NGM (n 1796) IGM (n 470) ND T2DM (n 125)
Mean SD Mean SD Mean SD
Demography
Age (years) 58·1 8·09 61·8 7·45 63·3 7·44
Sex (% male) 45·1 54·9 62·8
Lifestyle
Smoking (%)
Never 39·7 29·8 33·3
Ex 48·5 58·8 56·9
Current 11·8 11·5 9·76
BMI (kg/m2) 25·5 3·57 27·7 4·23 28·6 4·59
Physical activity (h/week) 15·0 8·15 14·3 7·79 13·1 7·34
Dietary intake
Energy (kJ/d) 9347 2586 9439 2548 9096 2502
Energy (kcal/d) 2234 618 2256 609 2174 598
Carbohydrates, total (g/d) 243 75·3 238 70·0 232 68·1
Proteins, total (g/d) 86·2 22·9 87·4 21·9 83·8 21·1
Fats, total (g/d) 87·7 30·6 90·1 32·5 84·7 29·3
Vegetables (g/d) 191 105 193 99·0 176 93·3
Fruits (g/d) 188 140 178 143 172 138
Meat (g/d) 99·2 54·1 117 60·4 112 50·8
Fish (g/d) 21·8 18·9 22·1 19·3 21·1 17·9
Biological
Systolic blood pressure (mmHg) 131 17·2 138 17·1 143 19·0
Diastolic blood pressure (mmHg) 75·2 9·89 77·9 9·58 79·1 10·3
Cholesterol (mmol/l) 5·57 1·03 5·46 1·15 5·32 1·24
HDL (mmol/l) 1·66 0·49 1·50 0·42 1·36 0·38
LDL (mmol/l) 3·37 0·94 3·26 1·03 3·16 1·14
TAG (mmol/l) 1·22 0·66 1·61 1·08 1·91 1·09
Medical history of CVD (% yes) 12·3 14·1 23·4
NGM, normal glucose metabolism; IGM, impaired glucose metabolism; ND T2DM, newly diagnosed type 2 diabetes mellitus.
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adjusted for potential confounders. To prevent reporting bias,
participants filled out the FFQ before results of the OGTT became
available, and only individuals with ND T2DM (screen-diagnosed
diabetes) were included. Results showed a strong inverse asso-
ciation between total dairy product intake and ND T2DM, with an
OR of 0·50 (95% CI 0·26, 0·93) for the highest v. lowest tertile of
intake, but a marked positive association between full-fat dairy
products and T2DM (OR 2·01; 95% CI 1·16, 3·47). Remarkably,
these associations were completely absent for IGM (OR 0·98 for
the highest tertile v. lowest of total dairy and 0·90 for full-fat
products). Fermented products and yogurt were inversely asso-
ciated with T2DM (OR< 0·60) and the same was observed for
IGM (OR< 0·75). An inverse association with IGM was found for
skimmed dairy products (OR for the top v. bottom tertile of
intake: 0·73 (95% CI 0·55, 0·96)), which was non-significant for
ND T2DM despite a similar OR (0·76 (95% CI 0·44, 1·32)). Finally,
the consumption of cheese showed a significant negative asso-
ciation with IGM (OR per serving (20 g): 0·88 (95% CI 0·80, 0·97))
but not with T2DM (OR per serving: 1·05 (95% CI 0·90, 1·22)).
Four meta-analyses(8,10–12) revealed combined hazard ratio of
0·85(8) and 0·86(12) for highest v. lowest categories of total dairy
consumption – 0·80(11) to 0·93(10) for 200 and 400 g increment of
total dairy product intake(11), respectively. Our results con-
firmed this inverse association, but associations in our study
were more pronounced with an estimated 50% lower odds of
T2DM in individuals in the third tertile (total dairy product
intake >188 g/d) as compared with individuals in the first tertile
(total dairy product intake <87 g/d). Published studies also
showed inverse associations of both skimmed and full-fat dairy
products(14) with T2DM. The present study showed a positive
association of full-fat products with ND T2DM, but not with
IGM. In addition, skimmed products were significantly inversely
associated with IGM, but not with ND T2DM. This is in contrast
with a recent prospective study showing an inverse association
of full-fat dairy products with T2DM risk and no association
between skimmed products and T2DM risk(20). Several other
studies showed a negative association of skimmed products
with T2DM risk but no association of full-fat dairy products with
Table 3. Cross-sectional associations between intake of dairy products and impaired glucose metabolism
(Odds ratios and 95% confidence intervals)*
Continuous Tertile 1 Tertile 2 Tertile 3
OR 95% CI OR OR 95% CI OR 95% CI Ptrend
Total dairy products (per 100 g) ≤87·5 g/d 87·5–187·6 g/d ≥187·6 g/d
Model 1† 0·91 0·84, 0·99 1 0·93 0·73, 1·18 0·76 0·59, 0·97 0·03
Model 2‡ 0·97 0·89, 1·07 1 1·07 0·81, 1·42 0·98 0·73, 1·33 0·92
Full-fat products (per 100 g) ≤4·26 g/d 4·26–23·01 g/d ≥23·01 g/d
Model 1† 0·91 0·68, 1·22 1 0·89 0·70, 1·14 0·81 0·64, 1·04 0·09
Model 2‡ 0·99 0·70, 1·40 1 0·91 0·69, 1·20 0·90 0·67, 1·21 0·47
Semi-skimmed products (per 100 g) ≤2·75 g/d 2·75–64·13 g/d ≥64·13 g/d
Model 1† 0·92 0·81, 1·03 1 0·93 0·73, 1·18 0·80 0·62, 1·02 0·07
Model 2‡ 1·00 0·88, 1·13 1 0·92 0·69, 1·23 0·96 0·72, 1·27 0·76
Skimmed products (per 100 g) ≤6·50 g/d 6·50–43·48 g/d ≥43·48 g/d
Model 1† 0·93 0·81, 1·06 1 0·81 0·64, 1·04 0·77 0·60, 0·98 0·03
Model 2‡ 0·94 0·82, 1·07 1 0·72 0·55, 0·96 0·73 0·55, ·96 0·04
Fermented products (per 100 g) ≤61·2 g/d 61·2–135·6 g/d ≥135·6 g/d
Model 1† 0·85 0·76, 0·95 1 0·65 0·51, 0·83 0·62 0·48, 0·79 <0·01
Model 2‡ 0·92 0·81, 1·04 1 0·69 0·52, 0·92 0·74 0·54, 0·99 0·04
Non-fermented products, basic (per 100 g) ≤1·13 g/d 1·13–35·1 g/d ≥35·1 g/d
Model 1† 0·96 0·85, 1·09 1 0·97 0·76, 1·24 1·00 0·78, 1·24 0·99
Model 2‡ 1·00 0·88, 1·14 1 0·90 0·68, 1·21 1·05 0·78, 1·21 0·72
Non-fermented products, desserts (per 100 g) ≤5·84 g/d 5·84–26·07 g/d ≥26·07 g/d
Model 1† 1·11 0·88, 1·39 1 1·10 0·86, 1·40 0·90 0·70, 1·15 0·43
Model 2‡ 1·22 0·94, 1·59 1 1·14 0·86, 1·52 0·99 0·73, 1·35 0·96
Milk (per serving (150 g)) Non-cons 0·1–43·5 g/d ≥43·5 g/d
Model 1† 0·94 0·73, 1·21 1 1·01 0·77, 1·31 1·10 0·86, 1·41 0·08
Model 2‡ 1·01 0·77, 1·31 1 0·89 0·66, 1·20 1·10 0·84, 1·45 0·54
Cheese, total (per serving (20 g)) ≤17·5 g/d 17·5–39·8 g/d ≥39·8 g/d
Model 1† 0·89 0·82, 0·97 1 0·95 0·75, 1·21 0·67 0·52, 0·87 <0·01
Model 2‡ 0·89 0·81, 0·97 1 1·04 0·79, 1·36 0·75 0·55, 1·01 0·07
Cheese, Dutch (per serving (20 g)) ≤15·4 g/d 15·4–34·3 g/d ≥34·4 g/d
Model 1† 0·89 0·81, 0·97 1 0·88 0·69, 1·12 0·69 0·54, 0·88 <0·01
Model 2‡ 0·88 0·80, 0·97 1 0·93 0·70, 1·23 0·76 0·57, 1·01 0·06
Yogurt, total (per serving (150 g)) ≤10.5 g/d 13·5–63g/d ≥63 g/d
Model 1† 0·77 0·61, 0·96 1 0·73 0·57, 0·94 0·61 0·48, 0·78 <0·01
Model 2‡ 0·90 0·71, 1·15 1 0·72 0·54, 0·97 0·67 0·50, 0·90 <0·01
Curd cheese, total (per serving (150 g)) Non-cons 0·1–9 g/d ≥9 g/d
Model 1† 0·96 0·62, 1·46 1 0·85 0·65, 1·10 0·90 0·70, 1·16 0·71
Model 2‡ 1·05 0·67, 1·64 1 1·01 0·76, 1·36 0·94 0·71, 1·25 0·42
Non-cons, non-consumers.
* Continuous analyses: milk, cheese, yogurt and curd cheese per serving increment, all combined dairy categories per 100 g increment.
† Model 1 adjusted for age and sex.
‡ Model 2 additionally adjusted for BMI, physical activity, smoking status, education and intakes of energy, vegetables, fruits, meat and fish.
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T2DM risk(32,33). Although it is unclear why full-fat products
were positively associated with T2DM in our study, but not with
IGM, one possible reason may have been the relatively low
number of individuals with ND T2DM (n 125), which may have
led to a false-positive finding. In addition, the heterogeneity of
the IGM population may have attenuated the association, which
may explain this difference. Future studies need to further
investigate associations of skimmed and full-fat dairy products
with IGM and T2DM risk.
There is very less information on the association between
single dairy products and T2DM risk. Meta-analyses and a recent
study have shown that milk consumption was inversely(8) or not
associated with the risk of T2DM in fully adjusted models(10–12,20).
In our study, the null finding for milk consumption was confirmed
for both T2DM and IGM. Although some studies did not reveal
an association of cheese consumption with the incidence
of the metabolic syndrome and/or T2DM(13,20), a meta-analysis
showed an 8(10) to 20%(11) reduction in relative risk per 50(10) or
30 g(11) increment in cheese consumption. In our population,
cheese consumption was not associated with ND T2DM, but a
significantly lower odds of IGM of 11% was observed
per serving (20 g) of cheese, which corresponded with a lower
odds of IGM of 26 and 16% per 50 and 30 g increment (data
not shown), respectively. In line with a potential inverse
association of cheese consumption on diabetes risk, a recent
randomised controlled trial showed significant decreases in
total cholesterol and waist circumference after increased
cheese consumption for a period of 8 weeks in individuals
with the metabolic syndrome(34). Our finding that consumption
of yogurt and fermented products was inversely associated
with both T2DM and IGM is also consistent with previous
studies(10–12,18). In line with this, a cross-sectional study per-
formed within the Framingham Heart Study Offspring and Third
Generation cohorts revealed that individuals who consumed
yogurt had a better diet quality as compared with non-
consumers. In addition, yogurt consumption was associated
with lower circulating levels of glucose and TAG, as well as
with lower systolic blood pressure and insulin resistance(35).
Table 4. Cross-sectional associations between intake of dairy products and newly diagnosed type 2 diabetes mellitus
(Odds ratios and 95% confidence intervals)*
Continuous Tertile 1 Tertile 2 Tertile 3
OR 95% CI OR OR 95% CI OR 95% CI Ptrend
Total dairy ≤87·5 g/d 87·5–187·6g/d ≥187·6 g/d
Model 1† 0·74 0·61, 0·88 1 1·17 0·78, 1·74 0·42 0·25, 0·71 <0·01
Model 2‡ 0·76 0·61, 0·95 1 1·38 0·86, 2·24 0·50 0·26, 0·93 0·06
Full-fat products ≤4·26 g/d 4·26–23·01g/d ≥23·01 g/d
Model 1† 1·14 0·71, 1·83 1 1·16 0·73, 1·85 1·50 0·87, 2·33 0·07
Model 2‡ 1·60 0·93, 2·76 1 1·32 0·77, 2·28 2·01 1·16, 3·47 0·01
Semi-skimmed products ≤2·75 g/d 2·75–64·13g/d ≥64·13 g/d
Model 1† 0·71 0·54, 0·94 1 0·96 0·63, 1·46 0·58 0·37, 0·93 0·03
Model 2‡ 0·75 0·55, 1·02 1 0·85 0·52, 1·40 0·60 0·35, 1·02 0·06
Skimmed products
Model 1† 0·72 0·52, 0·99 1 0·95 0·62, 1·45 0·83 0·52, 1·30 0·42
Model 2‡ 0·71 0·48, 1·04 1 0·85 0·51, 1·41 0·76 0·44, 1·32 0·32
Fermented products ≤61·2 g/d 61·2–135·6g/d ≥135·6 g/d
Model 1† 0·59 0·45, 0·77 1 0·64 0·42, 0·98 0·42 0·26, 0·68 <0·01
Model 2‡ 0·69 0·50, 0·94 1 0·76 0·46, 1·26 0·57 0·32, 1·01 0·05
Non-fermented products, basic ≤1·13 g/d 1·13–35·1 g/d ≥35·1g/d
Model 1† 0·84 0·66, 1·07 1 1·09 0·70, 1·69 1·05 0·67, 1·65 0·82
Model 2‡ 0·80 0·60, 1·07 1 0·89 0·53, 1·50 0·85 0·50, 1·45 0·56
Non-fermented products, desserts ≤5·84 g/d 5·84–26·07g/d ≥26·07 g/d
Model 1† 0·75 0·46, 1·21 1 1·44 0·92, 2·24 1·03 0·65, 1·64 0·89
Model 2‡ 0·78 0·44, 1·38 1 1·59 0·94, 2·71 1·14 0·64, 2·02 0·71
Milk (per serving (150 g)) Non-cons 0·1–43·5 g/d ≥43·5g/d
Model 1† 0·68 0·41, 1·15 1 1·20 0·77, 1·87 0·92 0·58, 1·45 0·74
Model 2‡ 0·62 0·33, 1·15 1 1·16 0·70, 1·92 0·81 0·48, 1·39 0·53
Cheese, total (per serving (20 g)) ≤17·5 g/d 17·5–39·8 g/d ≥39·8g/d
Model 1† 0·96 0·84, 1·09 1 0·88 0·57, 1·37 0·89 0·57, 1·39 0·61
Model 2‡ 1·03 0·89, 1·18 1 0·94 0·56, 1·58 1·15 0·68, 1·97 0·60
Cheese, Dutch (per serving (20 g)) ≤15·4 g/d 15·4–34·3 g/d ≥34·4g/d
Model 1† 0·99 0·86, 1·13 1 0·97 0·61, 1·53 0·98 0·63, 1·51 0·91
Model 2‡ 1·05 0·90, 1·22 1 1·07 0·62, 1·83 1·26 0·74, 2·13 0·39
Yogurt, total (per serving (150 g)) ≤10·5 g/d 13·5–63 g/d ≥63g/d
Model 1† 0·36 0·21, 0·64 1 0·79 0·51, 1·23 0·54 0·35, 0·85 <0·01
Model 2‡ 0·47 0·24, 0·89 1 0·87 0·52, 1·45 0·60 0·35, 1·02 0·06
Curd cheese, total (per serving (150 g)) Non-cons 0·1–9 g/d ≥9 g/d
Model 1† 0·34 0·09, 1·30 1 0·57 0·34, 0·95 0·67 0·42, 1·06 0·05
Model 2‡ 0·49 0·33, 0·72 1 0·74 0·42, 1·31 0·79 0·46, 1·36 0·15
Non-cons, non-consumers.
* Continuous analyses: milk, cheese, yogurt and curd cheese per serving increment, all combined dairy categories per 100 g increment.
† Model 1 adjusted for age and sex.
‡ Model 2 additionally adjusted for BMI, physical activity, smoking status, education and intakes of energy, vegetables, fruits, meat and fish.










aastricht , on 16 Sep 2021 at 06:43:48 , subject to the Cam
bridge Core term






Furthermore, fermentation may enhance the nutritional value of
yogurt and provide it with unique properties that enhance the
bioavailability of some nutrients(36) and reduce blood pressure
and LDL-cholesterol(37). In contrast, the recently published
Seguimiento Universidad de Navarra (SUN) study revealed no
associations between yogurt consumption and the incidence of
the metabolic syndrome during a 6-year follow-up period(38).
The mechanisms underlying alleged protective effects of total
dairy products or fermented products on T2DM are not well
understood. It has been hypothesised that dairy product intake
may be inversely associated with T2DM through a protective
role of vitamin D, Ca, Mg and whey proteins present in dairy
products(39). As dairy products in the Netherlands are not
fortified with vitamin D, this vitamin is unlikely to play a role in
the present study results. Ca increases insulin secretion and is
essential for insulin-responsive tissues such as skeletal muscle
and adipose tissue and may reduce insulin resistance(40).
Furthermore, Mg intake has been associated with reduced
diabetes risk in epidemiological studies(41) and with improved
insulin sensitivity in some experimental studies, although data
are limited(42). Dairy products also contain whey proteins,
which in animal models have been shown to reduce body
weight gain and to increase insulin sensitivity(43). In contrast
with these potentially protective nutrients, dairy products
are also rich sources of SFA, which were associated with
insulin resistance in some but not all controlled trials and
prospective studies(44). In the recent EPIC-InterAct study,
plasma levels of even-chain SFA were positively associated
with incident T2DM, whereas odd-chain SFA were inversely
associated with incident T2DM(45). As SFA can be synthesised
in the human body, the physiological implication of this
finding remains to be elucidated. Two studies revealed that
higher plasma levels of trans-palmitoleic acid, which is
indicative of dairy fat consumption, were associated with a
reduced diabetes risk(5,15). In addition, animal studies showed
that butyrate consumption, one of the main fatty acids in dairy
products, could protect from obesity and increase insulin
sensitivity(7).
It is possible that the observed inverse association of Dutch
cheese, yogurt, skimmed and fermented products with IGM and
of total dairy product intake and high-fat dairy product intake
with ND T2DM reflects a general difference in lifestyle habits.
For instance, in our study population, higher intake of total
dairy products was associated with healthier lifestyle reflected
by higher levels of physical activity, lower prevalence of
smoking and overweight/obesity, lower intakes of meat
and higher intakes of fruits and vegetables. Even though asso-
ciations between specific dairy products remained significant
after adjustment for these variables, the possibility of residual
confounding cannot be fully disregarded.
Our study has several strengths and limitations. A major
limitation is the cross-sectional design of our study, which
formally rules out causal inference. Nevertheless, we believe that
our analyses do add to the existing evidence on the relationship
between dairy product intake and T2DM, as all participants
completed the FFQ before being informed about their glucose
metabolism status, which minimised the risk of reporting bias.
Furthermore, subjects with known pre-existing T2DM (n 883)
were excluded from the present analyses, which makes it quite
unlikely that subjects with ND T2DM could have adapted their
diet to their disease status.
It may be noted that our results are generally in line with
associations observed in previous prospective studies, which
corroborates the integrity of our findings. A strength of our
study is the fact that we have reported unique data on IGM,
which have not been published before. Nevertheless, of note,
IGM is a mixed population defined as the presence of either an
elevated fasting glucose level, an IGT test or the combination of
both. Furthermore, extensive information on lifestyle factors
was collected for each cohort member, allowing the adjustment
for potential confounders. Another important strength of
this study is the extensive collection of dairy product intake
data. We believe that the FFQ used in the Maastricht Study
optimally estimated dairy product intake as our extensive FFQ
captured fifty dairy food items.
In conclusion, this is the first study on the associations of
dairy products with both ND T2DM and IGM. Intakes in the top
tertiles of yogurt and fermented products were cross-sectionally
associated with lower odds of presenting ND T2DM and IGM
by 25–40% relatively to intakes in the bottom tertiles. This
observed association is consistent with the hypothesis that
yogurt and fermented products may play a role in the aetiology
of diabetes. However, associations of total dairy product intake,
full-fat products, skimmed products and Dutch cheese did not
reveal similar direction and magnitude for ND T2DM and IGM.
Therefore, our results warrant further assessment of the
relationship between single dairy products and the incidence of
IGM and T2DM in a prospective design to elucidate their role in
T2DM development.
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